SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001815776-24-000044
Filing Date
2024-05-14
Accepted
2024-05-14 17:29:43
Documents
1
Period of Report
2024-05-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1715722170.html 4  
1 FORM 4 wk-form4_1715722170.xml 4 4163
  Complete submission text file 0001815776-24-000044.txt   5833
Mailing Address C/O LENZ THERAPEUTICS, INC. 445 MARINE VIEW AVE SUITE 320 DEL MAR CA 92014
Business Address
MCCOLLUM JAMES W (Reporting) CIK: 0001200889 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40532 | Film No.: 24945953

Mailing Address 445 MARINE VIEW AVE SUITE 320 DEL MAR CA 92014
Business Address 445 MARINE VIEW AVE SUITE 320 DEL MAR CA 92014 858-925-7000
LENZ Therapeutics, Inc. (Issuer) CIK: 0001815776 (see all company filings)

IRS No.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)